-
01.09.2026 | Clarametyx Biosciences announces positive topline data from Phase 2a study evaluating CMTX-101 in cystic fibrosis
CMTX-101 treatment produced clinically meaningful reductions in key inflammatory biomarkers and pulmonary Pseudomonas aeruginosa burden, and preservation of pulmonary function.
-
01.08.2026 | Quest, Labcorp add fully at-home STI test to women’s health offerings
Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the potential demand for quick, at-home testing for women’s sexual health.
Toggle navigation